Patrick Sullivan, MD
Colon & Rectal Surgery · Atlanta, GANPI 1790969780
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,955 of the $41,065 with a category attached, or 72.9%. Merck accounts for 61.9% of it on its own, with 4 other manufacturers making up the rest.
Across 51 payments — averaging $805.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$25K
- Intuitive Surgical$8K
- Gilead$7K
- Medtronic$127
- Aroa Biosurgery Incorporated$57
Across 4 payments — averaging $77,125 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$308K
What the payments were for
- Consulting fees$29,95573%
- Travel & lodging$3,0637%
- Food & beverage$1,5474%
- Education$6,50016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $25,414 |
| Intuitive Surgical | 20 | $8,443 |
| Gilead | 9 | $7,024 |
| Medtronic | 1 | $127 |
| Aroa Biosurgery Incorporated | 2 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,066
- Signia$127
How this compares
$41,065 in reported general payments places this provider in the 85th percentile of 66 colon & rectal surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $6,738 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 46 | $586 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $277 |
| Ondansetron OdtOndansetron | 14 | $207 |
| Tramadol Hcl | 38 | $63 |
| Oxycodone Hcl | 18 | $63 |
| Gabapentin | 12 | $45 |
| Metronidazole | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Atlanta
- Sander BinderowAtlanta$20K
- Daniel Sarmiento GarzonAtlanta$14K
- Joseph MarenoAtlanta$13K
- Jessica LamAtlanta$8K
- Evan FeldmanAtlanta$7K
- Cici ZhangAtlanta$5K
- Ellen CaparosaAtlanta$5K
- Monica HumAtlanta$5K
- Gie YuAtlanta$3K
- Stephanie PappasAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.